Uma Naidoo, MD: The Food-Mind Connection
Episode #51 of the Charged podcast
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Contact Information
149 13th Street, 10th Floor
Charlestown,
MA
02129
Our focus is on neurotherapeutic interventions for severe, treatment-resistant psychiatric illnesses. We focus in particular on major depressive disorder and obsessive-compulsive disorder.
Our research spans mechanistic studies, clinical trials and device-based interventions employing a variety of techniques, including neuroimaging and electrophysiology. We also provide clinical services and surgical treatments for psychiatric illness.
Our work utilizes functional and structural magnetic resonance imaging (fMRI), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS) and deep brain stimulation (DBS) to further understanding of psychiatric illness and treatment.
This multi-year integrated translational neuro-engineering project proposes to co-develop a new deep brain stimulation (DBS) system that actively senses a patient's brain activity, delivers electrical stimulation, and adjusts that stimulation in real time based on the brain's electrical response. These "closed loop" systems offer tremendous potential for bringing new hope to patients living with severe mental illness, especially particularly post-traumatic stress disorder (PTSD), depression, anxiety and addiction.
TRANSFORM DBS will create a new generation of medical devices that actively sense a patient's brain activity, deliver electrical stimulation, then adjust that stimulation in real time based on the brain's electrical response. These "closed loop" systems offer tremendous potential for bringing new hope to patients living with severe mental illness. Learn More
While past studies have been successful in identifying functional and neurochemical correlates of individual differences in reward motivation and impulsivity, assessment of causal mechanisms has remained elusive due to the inherent limitations of human neuroscience methods. Here, we test the causal role of human mesolimbic circuitry in reward motivation and impulsivity by examining a cohort of patients undergoing deep brain stimulation (DBS) within the ventral striatum. We examine behavior on and off stimulation across a range of tasks that index different forms of learning and motivation.
The long-term goal of this line of research is to help identify the neural circuitry underlying motivation for positive experiences, so as to better understand the etiopathophysiology of anhedonia and motivational deficits found across numerous psychiatric patient populations.
The purpose of this study is to examine patterns of connection and activation in brain regions of patients who have received or will receive cingulotomy or capsulotomy for treatment of major depressive disorder (MDD) or obsessive-compulsive disorder (OCD). The purpose of this investigation is to use high resolution MRI, specifically diffusion tensor imaging (DTI), as well as resting state MRI, to look at the connection patterns in patients who have been treated with cingulotomy or capsulotomy for MDD or OCD, as compared to healthy controls.
Currently in the analysis stage, this project seeks to investigate the feasibility and acceptability of transdiagnostic cognitive behavioral therapy with the Unified Protocol in treating a full range of anxiety and unipolar mood disorders in individuals with BP-I disorder and comorbid anxiety.
Further, the present study uses fcMRI to explore potential biomarkers of individual treatment response to this approach. By applying a transdiagnostic approach to the treatment of patients with bipolar disoder, this study may offer the possibility of treating bipolar disorder and comorbid anxiety by using a single psychosocial treatment protocol, providing a unique opportunity to investigate whether a transdiagnostic approach is also a feasible approach to treating bipolar disorder.
The purpose of this study is to investigate the neural correlate relating to fear and how activation in these regions covaries with self-report levels of fear and galvanic skin response. In conjunction with fMRI and experimental tasks, this study also looks at the brain anatomy in patients other than the amygdala that contributes to the feeling of fear.
Joan Camprodon-Gimenez, MD, PhD
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
Afsana Afzal
Amanda Arulpragasam
M. Taha Bilge, PhD
Andrew Corse
Julia Felicione
Anna Gilmour
Aishwarya Gosai
Emily Hahn
Alex Rockhill
Alexandra Rodman
Alik Widge, MD, PhD
Sam Zorowitz
Fontenelle LF, Oldenhof E, Eduarda Moreira-de-Oliveira M, Abramowitz JS, Antony MM, Cath D, Carter A, Dougherty D, Ferrão YA, Figee M, Harrison BJ, Hoexter M, Soo Kwon J, Küelz A, Lazaro L, Lochner C, Marazziti D, Mataix-Cols D, McKay D, Miguel EC, Morein-Zamir S, Moritz S, Nestadt G, O'Connor K, Pallanti S, Purdon C, Rauch S, Richter P, Rotge JY, Shavitt RG, Soriano-Mas C, Starcevic V, Stein DJ, Steketee G, Storch EA, Taylor S, van den Heuvel OA, Veale D, Woods DW, Verdejo-Garcia A, Yücel M. A transdiagnostic perspective of constructs underlying obsessive-compulsive and related disorders: An international Delphi consensus study. Aust N Z J Psychiatry. 2020 May 04; 4867420912327. PMID: 32364439.
Testo AA, Felicione JM, Ellard KK, Peters AT, Chou T, Gosai A, Hahn E, Shea C, Sylvia L, Nierenberg AA, Dougherty DD, Deckersbach T. Neural correlates of the ADHD self-report scale. J Affect Disord. 2020 Feb 15; 263:141-146. PMID: 31818770.
Chou, T., Hooley, J.M. & Camprodon, J.A. Transcranial Direct Current Stimulation of Default Mode Network Parietal Nodes Decreases Negative Mind-Wandering About the Past. Cogn Ther Res 44, 10–20 (2020).
Provenza NR, Paulk AC, Peled N, Restrepo MI, Cash SS, Dougherty DD, Eskandar EN, Borton DA, Widge AS. Decoding task engagement from distributed network electrophysiology in humans. J Neural Eng. 2019 08 16; 16(5):056015. PMID: 31419211.
Zorowitz S, Rockhill AP, Ellard KK, Link KE, Herrington T, Pizzagalli DA, Widge AS, Deckersbach T, Dougherty DD. The Neural Basis of Approach-Avoidance Conflict: A Model Based Analysis. eNeuro. 2019 Jul/Aug; 6(4). PMID: 31346001.
Guerin B, Angelone LM, Dougherty D, Wald LL. Parallel transmission to reduce absorbed power around deep brain stimulation devices in MRI: Impact of number and arrangement of transmit channels. Magn Reson Med. 2020 01; 83(1):299-311. PMID: 31389069.
Yousefi A, Basu I, Paulk AC, Peled N, Eskandar EN, Dougherty DD, Cash SS, Widge AS, Eden UT. Decoding Hidden Cognitive States From Behavior and Physiology Using a Bayesian Approach. Neural Comput. 2019 09; 31(9):1751-1788. PMID: 31335292.
Amidi Y, Paulk AC, Dougherty DD, Cash SS, Widge AS, Eden UT, Yousefi A. Continuous Prediction of Cognitive State Using A Marked-Point Process Modeling Framework. Conf Proc IEEE Eng Med Biol Soc. 2019 07; 2019:2933-2938. PMID: 31946505.
Dougherty DD. Will Deep Brain Stimulation Help Move Precision Medicine to the Clinic in Psychiatry? Biol Psychiatry. 2019 05 01; 85(9):706-707. PMID: 30999984.
Widge AS, Zorowitz S, Basu I, Paulk AC, Cash SS, Eskandar EN, Deckersbach T, Miller EK, Dougherty DD. Deep brain stimulation of the internal capsule enhances human cognitive control and prefrontal cortex function. Nat Commun. 2019 04 04; 10(1):1536. PMID: 30948727.
Basu I, Robertson MM, Crocker B, Peled N, Farnes K, Vallejo-Lopez DI, Deng H, Thombs M, Martinez-Rubio C, Cheng JJ, McDonald E, Dougherty DD, Eskandar EN, Widge AS, Paulk AC, Cash SS. Consistent linear and non-linear responses to invasive electrical brain stimulation across individuals and primate species with implanted electrodes. Brain Stimul. 2019 Jul - Aug; 12(4):877-892. PMID: 30904423.
Ellard KK, Gosai AG, Bernstein EE, Kaur N, Sylvia LG, Camprodon JA, Dougherty DD, Nierenberg AA, Deckersbach T. (2018). Intrinsic functional neurocircuitry associated with treatment response to transdiagnostic CBT in bipolar disorder with anxiety. Journal of Affective Disorders.
Deckersbach T, Peters AT, Shea C, Gosai A, Stange JP, Peckham AD, Ellard KK, Otto MW, Rauch SL, Dougherty DD, Nierenberg AA. (2018). Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging. Journal of Affective Disorders.
Widge AS, Ellard KK, Paulk AC, Basu I, Yousefi A, Zorowitz S, Gilmour A, Afzal A, Deckersbach T, Cash SS, Kramer MA, Eden UT, Dougherty DD, Eskandar EN. (2017). Treating refractory mental illness with close-loop brain stimulation: Progress towards a patient-specific transdiagnostic approach. Experimental Neurology.
Taha Bilge M, Gosai AK, Widge AS. (2018). Deep Brain Stimulation in Psychiatry: Mechanisms, Models, and Next-Generation Therapies. Psychiatric Clinics of North America.
Dougherty DD, Chou T, Corse AK, Arulpragasam AR, Widge AS, Cusin C, Evans KC, Greenberg BD, Haber SN, Deckersbach T. (2016). Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder. Journal of Neurosurgy.
Widge, A. S., Zorowitz, S., Link, K., Miller, E. K., Deckersbach, T., Eskandar, E. N., & Dougherty, D. D. (2015). Ventral Capsule/Ventral Striatum Deep Brain Stimulation Does Not Consistently Diminish Occipital Cross-Frequency Coupling. Biological Psychiatry.
Widge, A. S., Arulpragasam, A. R., Deckersbach, T., & Dougherty, D. D. (2015). Deep brain stimulation for psychiatric disorders. Emerging trends in the social and behavioral sciences: An interdisciplinary, searchable, and linkable resource.
Widge, A.S., Deckersbach, T., Eskandar, E. N. & Dougherty, D. D. Deep Brain Stimulation for Treatment-Resistant Psychiatric Illnesses: What Has Gone Wrong and What Should We Do Next? Biological Psychiatry. 2015 Jun 10.
Widge, A. S., & Dougherty, D. D. (2015). Deep Brain Stimulation for Treatment-Refractory Mood and Obsessive-Compulsive Disorders. Current Behavioral Neuroscience Reports, 2(4), 187-197.
Nierenberg, A., Peters, A., Stange, J., Sylvia, L.G., Otto, M.W., Miklowitz, D.J., Dougherty, D.D., Deckerbach, T. Neural predictors of response to psychotherapy for depression in bipolar disorder. Bipolar Disorders. 17(47-47), 2015.
Makris, N., Rathi, Y., Mouradian, P., Bonmassar, G., Papadimitriou, G., Ing, W. I., ... & Dougherty, D. D. (2015). Variability and anatomical specificity of the orbitofrontothalamic fibers of passage in the ventral capsule/ventral striatum (VC/VS): precision care for patient-specific tractography-guided targeting of deep brain stimulation (DBS) in obsessive compulsive disorder (OCD). Brain imaging and behavior, 1-14.
Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Howland, R. H., Bhati, M. T., O’Reardon, J. P., ... & Malone, D. A. (2014). A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression. Biological psychiatry.
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., ... & Greenberg, B. D. (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological psychiatry, 65(4), 267-275.
Corse, A. K., Chou, T., Arulpragasam, A. R., Kaur, N., & Cusin, C. (2013). Deep brain stimulation for obsessive-compulsive disorder. Psychiatric Annals,43(8), 351.
Kaur, N., Chou, T., Corse, A. K., Arulpragasam, A. R., Deckersbach, T., & Evans, K. C. (2013). Deep brain stimulation for treatment-resistant depression. Psychiatric Annals, 43(8), 358.
For 80 years, Mass General's Psychiatry Department has provided the highest quality patient care through pioneering research.
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
For 80 years we've provided the highest quality patient care, conducted pioneering research and educated professionals in the field.
Episode #51 of the Charged podcast
The center’s mission is to understand how psychedelics enhance the brain’s capacity for change, to optimize current treatments and create new treatments for mental illness and to render the term “treatment resistant” obsolete.
With recommendations to stay at home this winter to help stop the spread of COVID-19, David Mischoulon, MD, PhD, offers insights on SAD and how to stay well at home this winter.
Episode #51 of the Charged podcast
With overdose deaths rising, researchers argue that one potential tool for stigma reduction—terminology—is crucial to study.
Mai Uchida, MD, shares her “My Why”—outlining her decision to get the COVID vaccine during her pregnancy. Dr. Uchida hopes that she can be of help to anyone struggling with a similar decision by sharing her thought process, her emotions as a mother and her expertise as a physician.
As a world leader in medical discovery and patient care, Mass General Neuroscience brings together the expansive expertise and passion from our Psychiatry, Neurosurgery and Neurology Departments. Through Advances in Motion, we provide health care professionals with information about our latest breakthroughs, research and clinical advances.